Silverback Therapeutics ^Investors

Silverback Therapeutics is an angel group based in Seattle, Washington, founded in 2016 The organization focuses on advancing innovative therapeutic solutions, particularly in the field of oncology With a significant investment scale of $277,725,000, Silverback Therapeutics aims to support the development of groundbreaking treatments The group is dedicated to fostering collaboration among entrepreneurs and investors to drive progress in the healthcare sector Their commitment to addressing unmet medical needs positions them as a key player in the biotechnology landscape